sitemap.xml - Search
About 2,370 results
Open links in new tab
    Kizdar net | Kizdar net | Кыздар Нет
  1. Weight maintenance after discontinuation of GLP-1 therapies

    Real-world data show that up to 65% of users discontinue GLP-1 RAs within a year of initiation, and randomized controlled trials …

  2. Maintaining Weight Loss After Stopping GLP-1 (2026)

    Jun 2, 2026 · The trial demonstrated that pharmacological action is required to maintain weight loss — lifestyle intervention alone …

  3. Trajectory of weight regain after cessation of GLP-1 receptor agonists ...

    In this systematic review, we aimed to characterise the trajectory of weight regain after GLP-1RA cessation. This systematic review …

  4. Weight maintenance after discontinuation of GLP-1 therapies

    Jun 1, 2026 · Real-world data show that up to 65% of users discontinue GLP-1 RAs within a year of initiation, and randomized …

  5. Stopping GLP-1s in 2026: What New Real-World Data Actually Shows

    Jul 13, 2026 · The SURMOUNT-MAINTAIN trial (Lancet, June 2026) looked at a related but distinct question — what happens to …

  6. Weight maintenance after discontinuation of GLP-1 therapies

    Real-world data show that up to 65% of users discontinue GLP-1 RAs within a year of initiation, and randomized controlled trials …

  7. Life After GLP-1: Maintenance, Tapering & Stopping (2026)

    Aug 2, 2026 · Home / Research / Life After GLP-1: Maintenance Dosing, Microdosing, Tapering & What Happens When You Stop …

  8. Weight Regain After Stopping GLP-1 Medications: What Research …

    Mar 28, 2026 · Patients who combined GLP-1 therapy with behavioral counseling and structured dietary change retain more weight …

  9. Weight Regain After Stopping GLP-1s: What the Withdrawal Data Shows

    Jul 14, 2026 · Across the published withdrawal trials, stopping a GLP-1 (glucagon-like peptide-1, a gut hormone that signals satiety …

  10. Clinical Management of Weight Regain and Cardiometabolic …

    Mar 26, 2026 · Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual incretin therapies produce substantial weight loss …